Study on the risk of patiens with familial hypercholesterolemia by the determination of apolipoprotein E phenotyping
Study on the risk of patiens with familial hypercholesterolemia by the determination of apolipoprotein E phenotyping
批准号:
07670845
负责人:
ASAMI Tadashi
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997
中文摘要
点击翻译按钮获取中文摘要
英文摘要
In familial hypercholelsterolemia (FH), the inter-individual variability in serum total cholesterol (TC) kevels raises a possibility that some still unknown factors, other than LDL receptors, may also contribute to them. Apolipoprotein E (apoE) is a plasma protein involved in cholesterol transport and metaboslim. The allelic variation in the apoE gene (E2/2, E2/3, E2/4, E3/3, E4/3, and E4/4.) is responsible for a proportion of the inter-individual variability in serum TC.With this background in mind, we investigated the association of apoE phenotypes with serum TC levels in FH children.In 269 pediatric patients (hypercholesterolemia, hypothyroidism, malignant diseases, chance proteinuria and/or hematuria, renal diseases), apoE phenotypes were as follows ; E3/3 (192,71.6%), E4/3 (45,16.8%), E3/2 (24,9.0%), E5/3 (5,1.9%), and a very rare variant E7/4.The apoE phenotype of the 143 normal control subjects was E3/3 (100,70.0%) ; E4/3(29,20.4%) ; E3/2 (10,7.0%) ; and E4/2 and E5/3 (4,2.8%). Children with FH had no significant differences in each apoE phenotype distribution as comapared with the normal children. FH children without E4 allele had a tendency to respond cholesterol lowering therapy. In addition, obese children, with at least one E4 allele, had higher serum apoB levels, suggesting higher risk for future coronary atherosclerosis, and nephrotic children with at least one E4 allele were shown to be more steroid resistant.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Asami T, et al.: "Two families of Lowe oculocerebrorenal syndrom with elevated serum HDL cholesterol levels and CETP gene mutation." Acta Paed Int J Paed. 86・1. 41-45 (1997)
Asami T 等:“血清 HDL 胆固醇水平升高和 CETP 基因突变的 Lowe 眼脑肾综合征的两个家族。”Acta Paed Int J Paed 86·1 (1997)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asami T, Gomi T, et al: "Persistent non-familial asymptomatic hyperphosphatasemia:a report on three cases." Acta Paediatrica Int J Pead. 84. 346-348 (1995)
Asami T、Gomi T 等人:“持续性非家族性无症状高磷酸酶血症:三例报告”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asami T, et al.: "Incidence of febrile convusions in children with congenital hypothyroidism." Acta Paed. (印刷中). (1998)
Asami T 等人:“先天性甲状腺功能减退症儿童的发热性惊厥的发生率”(Acta Paed)(1998 年)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asami T, Kikuchi T, et al: "Effects of L-thyroxine on serum lipid profiles in infants with congenital hypothyroidism." J Pediatr. 127. 812-814 (1995)
Asami T、Kikuchi T 等人:“L-甲状腺素对先天性甲状腺功能减退症婴儿血清脂质谱的影响”。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Asami T,et al.: "Cholesterol levels in children with renal diseases." Pediatiric Nephrology. (in press).
Asami T 等人:“肾病儿童的胆固醇水平。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 11 条
EFFECT OF TREATMENT OF INFANTS WITH BORDER-LINE CONGENITAL HYPOTHYROIDISM ON THEIR LATER THYROID FUNCTIONS
-
批准号:15591093
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.22万
-
财政年份:2003
-
负责人:ASAMI Tadashi
-
依托单位:
Treatment of Inflammmation by Purified Human Proteinase Inhibitor.
-
批准号:63570430
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.28万
-
财政年份:1988
-
负责人:ASAMI Tadashi
-
依托单位:
海外基金